Autophagy Function and Dysfunction: Potential Drugs as Anti-Cancer Therapy.
Francesca CuomoLucia AltucciGilda CobellisPublished in: Cancers (2019)
Autophagy is a highly conserved catabolic and energy-generating process that facilitates the degradation of damaged organelles or intracellular components, providing cells with components for the synthesis of new ones. Autophagy acts as a quality control system, and has a pro-survival role. The imbalance of this process is associated with apoptosis, which is a "positive" and desired biological choice in some circumstances. Autophagy dysfunction is associated with several diseases, including neurodegenerative disorders, cardiomyopathy, diabetes, liver disease, autoimmune diseases, and cancer. Here, we provide an overview of the regulatory mechanisms underlying autophagy, with a particular focus on cancer and the autophagy-targeting drugs currently approved for use in the treatment of solid and non-solid malignancies.
Keyphrases
- endoplasmic reticulum stress
- cell death
- oxidative stress
- induced apoptosis
- cell cycle arrest
- signaling pathway
- papillary thyroid
- quality control
- type diabetes
- cardiovascular disease
- heart failure
- stem cells
- squamous cell carcinoma
- squamous cell
- transcription factor
- drug delivery
- young adults
- skeletal muscle
- atrial fibrillation
- adipose tissue
- insulin resistance
- pi k akt
- lymph node metastasis
- smoking cessation
- free survival
- combination therapy